Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 64.00M | $ 38.00M | $ 80.00M | $ 32.00M | $ 41.00M |
Total Assets | $ 3.30B | $ 3.34B | $ 3.54B | $ 3.47B | $ 3.54B |
Total Debt | $ 1.28B | $ 1.25B | $ 1.17B | $ 1.07B | $ 1.03B |
Net Debt | $ 1.22B | $ 1.21B | $ 1.09B | $ 1.04B | $ 992.00M |
Total Liabilities | $ 2.57B | $ 2.53B | $ 2.48B | $ 2.39B | $ 2.39B |
Stockholders Equity | $ 772.00M | $ 825.00M | $ 1.06B | $ 1.08B | $ 1.15B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |